Drugs Abuse 12

Drugs Abuse – 12 Panel Test

Overview:
Drugs Abuse – 12 Panel is a urine-based screening test designed to detect the presence of multiple commonly abused drugs and their metabolites. It is useful for screening in clinical, workplace, rehabilitation, forensic, and substance-abuse monitoring settings.

What does it detect?
The 12-panel screening typically covers multiple drug classes such as:

• Amphetamines
• Methamphetamines
• Cocaine metabolites
• Opiates
• Benzodiazepines
• Barbiturates
• Cannabinoids (THC)
• Methadone
• Buprenorphine
• Tricyclic antidepressants
• Phencyclidine (PCP)
• MDMA/Ecstasy

Exact analytes may vary depending on the laboratory's test kit/panel.

Sample Required: Urine
Test Type: Drug screening
Purpose: Detection of recent exposure to selected drugs of abuse.

Why is it done?

• Substance-abuse screening
• Workplace drug testing
• Rehabilitation monitoring
• Clinical evaluation
• Pre-employment or compliance screening
• Monitoring suspected drug exposure

Important: A positive screening result is considered presumptive and may require confirmation using a more specific laboratory method such as GC-MS or LC-MS/MS.